Talk:CureVac: Difference between revisions
→Reply 08-MAY-2018: Fixing style/layout errors |
|||
Line 19: | Line 19: | ||
<!-- PLEASE READ: Please provide your requested edit after the {{request edit}} below in a roughly "replace X with Y" format. Explain the rationale behind the edit and provide reliable sources to support the proposed changes. At the end of the request, add four tildes "~~~~" and click "Save Page" --> |
<!-- PLEASE READ: Please provide your requested edit after the {{request edit}} below in a roughly "replace X with Y" format. Explain the rationale behind the edit and provide reliable sources to support the proposed changes. At the end of the request, add four tildes "~~~~" and click "Save Page" --> |
||
{{request edit|ans= |
{{request edit|ans=no}} |
||
I would like to request the following change: CureVac has entered into a collaboration with [[Eli Lilly and Company]] in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. |
I would like to request the following change: CureVac has entered into a collaboration with [[Eli Lilly and Company]] in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. |
||
Line 32: | Line 32: | ||
# Additional text was found to be insuffciently paraphrased from the source material. This text was integral to the lead section and the beginning of the main body of text, so it was ''not'' removed. A listing of that text may be found [https://tools.wmflabs.org/copyvios/?lang=en&project=wikipedia&oldid=839602019&action=compare&url=https%3A%2F%2Fwww.thegeniusworks.com%2F2017%2F04%2Fgamechangers-germany-industrial-precision-punk-entrepreneurship-new-generation-innovators-emerging%2F here]. in lieu of this removal, the [[Template:Close paraphrasing|close paraphrasing]] maintenance template was appended to the article. |
# Additional text was found to be insuffciently paraphrased from the source material. This text was integral to the lead section and the beginning of the main body of text, so it was ''not'' removed. A listing of that text may be found [https://tools.wmflabs.org/copyvios/?lang=en&project=wikipedia&oldid=839602019&action=compare&url=https%3A%2F%2Fwww.thegeniusworks.com%2F2017%2F04%2Fgamechangers-germany-industrial-precision-punk-entrepreneurship-new-generation-innovators-emerging%2F here]. in lieu of this removal, the [[Template:Close paraphrasing|close paraphrasing]] maintenance template was appended to the article. |
||
When ready to proceed with your response to point No. 1 above, kindly change the request edit template to read from '''ans=yes''' to '''ans=no'''. Thank you! <span style="font-size:75%;background:#008;border-radius:12px;">.[[User:Spintendo|<span style="background:#f00;border-radius:12px"><span style="background:#a02"><span style="background:#505"><span style="background:#008;color:#fff">'''spintendo'''</span>⋅</span>⋅</span>)</span>]]</span> 13:42, 8 May 2018 (UTC) |
When ready to proceed with your response to point No. 1 above, kindly change the request edit template to read from '''ans=yes''' to '''ans=no'''. Thank you! <span style="font-size:75%;background:#008;border-radius:12px;">.[[User:Spintendo|<span style="background:#f00;border-radius:12px"><span style="background:#a02"><span style="background:#505"><span style="background:#008;color:#fff">'''spintendo'''</span>⋅</span>⋅</span>)</span>]]</span> 13:42, 8 May 2018 (UTC) |
||
: Dear Spintendo, |
|||
: Thank you for working on the article. Since other collaborations are now no longer included in the history part, Eli Lilly does not have to be included there either. However, it would still make sense in the list of partners at the beginning - would you then still need further details or add the vague inline template if it is just listed? I could provide them, if necessary. |
|||
: How can I help to improve the article in order to discard the close paraphrasing and verification templates if I am not allowed to work in the article because of my COI? I would be grateful for advice. |
|||
: --[[User:VerenaLauterbach CureVacAG|VerenaLauterbach CureVacAG]] ([[User talk:VerenaLauterbach CureVacAG|talk]]) 14:42, 8 May 2018 (UTC) |
Revision as of 14:42, 8 May 2018
This is the talk page for discussing improvements to the CureVac article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Articles for creation Stub‑class | ||||||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent. |
Request edit on 8 May 2018
It is requested that an edit be made to the semi-protected article at CureVac. (edit · history · last · links · protection log)
This template must be followed by a complete and specific description of the request, that is, specify what text should be removed and a verbatim copy of the text that should replace it. "Please change X" is not acceptable and will be rejected; the request must be of the form "please change X to Y".
The edit may be made by any autoconfirmed user. Remember to change the |
I would like to request the following change: CureVac has entered into a collaboration with Eli Lilly and Company in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. https://endpts.com/eli-lilly-is-making-a-1-8b-leap-into-the-mrna-field-targeting-next-gen-cancer-vaccines/ and https://www.fiercebiotech.com/biotech/lilly-curevac-pen-1-8b-mrna-cancer-vaccine-deal Thank you for reviewing, --VerenaLauterbach CureVacAG (talk) 12:49, 8 May 2018 (UTC)
Reply 08-MAY-2018
- "Entering into collaboration" is a vague assertion which leaves out salient details like the purpose for the collaboration, and why. The text may be placed within the article without clarification, however, a vague inline template would be added along with it. Please advise if this is acceptable.
- Text within the article was found to be insufficiently paraphrased from the source material, and has been removed, per: WP:CLOSEPARAPHRASE. A listing of the text may be found here.
- Additional text was found to be insuffciently paraphrased from the source material. This text was integral to the lead section and the beginning of the main body of text, so it was not removed. A listing of that text may be found here. in lieu of this removal, the close paraphrasing maintenance template was appended to the article.
When ready to proceed with your response to point No. 1 above, kindly change the request edit template to read from ans=yes to ans=no. Thank you! .spintendo⋅⋅) 13:42, 8 May 2018 (UTC)
- Dear Spintendo,
- Thank you for working on the article. Since other collaborations are now no longer included in the history part, Eli Lilly does not have to be included there either. However, it would still make sense in the list of partners at the beginning - would you then still need further details or add the vague inline template if it is just listed? I could provide them, if necessary.
- How can I help to improve the article in order to discard the close paraphrasing and verification templates if I am not allowed to work in the article because of my COI? I would be grateful for advice.
- --VerenaLauterbach CureVacAG (talk) 14:42, 8 May 2018 (UTC)